Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT2A/2C receptors to modulate the post-ictal antinociception


Autoria(s): FREITAS, Renato Leonardo; BASSI, Gabriel Shimizu; OLIVEIRA, Ana Maria de; COIMBRA, Norberto Cysne
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

The post-ictal immobility syndrome is followed by a significant increase in the nociceptive thresholds in animals and humans. The aim of this study was to assess the involvement of the dorsal raphe nucleus (DRN) in the post-ictal antinociception. The second aim was to study the role of serotonergic intrinsic mechanisms of the DRN in this hypo-algesic phenomenon. Pentylenetetrazole (PTZ), an ionophore GABA-mediated Cl- influx antagonist, was peripherally used to induce tonic-clonic seizures in Wistar rats. The nociceptive threshold was measured by the tail-flick test. Neurochemical lesions of the DRN, performed with microinjection of ibotenic acid (1.0 mu g/0.2 mu L), caused a significant decrease of tonic-clonic seizure-induced antinociception, suggesting the involvement of this nucleus in this antinociceptive Process. Microinjections of methysergide (1.0 and 5.0 mu g/0.2 mu L), a non-selective serotonergic receptor antagonist, into DRN caused a significant decrease in the post-ictal antinociception in seizing animals, compared to controls, in all post-ictal periods Presently studied. These findings were corroborated by microinjections of ketanserin (at 1.0 and 5.0 mu g/0.2 mu L) into DRN. Ketanserin is an antagonist with large affinity for 5-HT2A/2C serotonergic receptors, which, in this Case, Caused a significant decrease in the tail-flick latencies in seizing animals, compared to controls after the first 20 min following tonic-clonic convulsive reactions. These results indicate that serotonergic neurotransmission of the DRN neuronal clusters is involved in the organization of the post-ictal hypo-algesia. The 5-HT2A/2C receptors of DRN neurons seem to be critically involved in the increase of nociceptive thresholds following tonic-clonic seizures. (c) 2008 Elsevier Inc, All rights reserved.

FAPESP[96/08574-9]

FAPESP[02/01496-5]

FAPESP[07/01174-1]

FAPESP[04/14786-7]

FAPESP[03105256-1]

FAPESP[TT-2]

FAPESP[02/01497-1]

FAEPA[537/1995]

FAEPA[70/2002]

CNPq[304421/2007-3]

CNPq[CNPq 057/2005]

Physiology, Anatomy and Genetics and Clinical Neurology (FMRIB Centre) Departments of the University of Oxford, Oxford, England, United Kingdom[200629/2005-0]

Bolsas de Apoio Tecnico

Ciencias da Vida[501858/2005-9]

Identificador

EXPERIMENTAL NEUROLOGY, v.213, n.2, p.410-418, 2008

0014-4886

http://producao.usp.br/handle/BDPI/24220

10.1016/j.expneurol.2008.07.003

http://dx.doi.org/10.1016/j.expneurol.2008.07.003

Idioma(s)

eng

Publicador

ACADEMIC PRESS INC ELSEVIER SCIENCE

Relação

Experimental Neurology

Direitos

restrictedAccess

Copyright ACADEMIC PRESS INC ELSEVIER SCIENCE

Palavras-Chave #post-ictal antinociception #tail-flick test #pain #dorsal raphe nucleus #serotonergic neurotransmission #5-HT2A/2C receptors #GABA-A receptor #pentylenetetrazole #tonic-clonic seizures #epilepsy #EPILEPSY-PRONE RATS #SUBSTANCE-INDUCED ANALGESIA #PERIAQUEDUCTAL GRAY-MATTER #FEAR-INDUCED ANALGESIA #ELECTRICAL-STIMULATION #INFERIOR COLLICULUS #SUPERIOR COLLICULUS #SEIZURE ACTIVITY #CHEMICAL-STIMULATION #MAGNUS STIMULATION #Neurosciences
Tipo

article

original article

publishedVersion